Inventor
NAKAJIMA MOTOWO
JP25 patents
⚠️ This page may combine multiple inventors who share the name “NAKAJIMA MOTOWO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SBI PHARMACEUTICALS CO LTD
12 patentsUS9399029B2Jul 26, 2016
Immune tolerance inducer
SBI PHARMACEUTICALS CO LTD5 citations71
US9351949B2May 31, 2016
Prophylactic/therapeutic agent for influenza virus infection
SBI PHARMACEUTICALS CO LTD2 citations57
US9962350B2May 8, 2018
Agent for improving normal development rate of fertilized eggs
SBI PHARMACEUTICALS CO LTD0 citations52
US9469598B2Oct 18, 2016
Erythropoietin production-promoting agent
SBI PHARMACEUTICALS CO LTD0 citations52
US10022345B2Jul 17, 2018
Agent for preventing and/or treating veisalgia
SBI PHARMACEUTICALS CO LTD0 citations50
US9937138B2Apr 10, 2018
Enhancer of survival of transplanted organ
SBI PHARMACEUTICALS CO LTD0 citations50
US9901558B2Feb 27, 2018
Enhancer of survival of transplanted organ
SBI PHARMACEUTICALS CO LTD0 citations50
US9539225B2Jan 10, 2017
Anemia of cancer improving/prophylactic agent
SBI PHARMACEUTICALS CO LTD0 citations50
US9475755B2Oct 25, 2016
Prophylactic agent for chronic kidney disease
SBI PHARMACEUTICALS CO LTD0 citations48
US9463175B2Oct 11, 2016
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
SBI PHARMACEUTICALS CO LTD0 citations48
US9707196B2Jul 18, 2017
Treatment agent and/or prophylactic agent for side effects of cancer drugs
SBI PHARMACEUTICALS CO LTD0 citations45
US9488664B2Nov 8, 2016
Diagnostic agent for tumor
SBI PHARMACEUTICALS CO LTD0 citations38
NOVARTIS AG
5 patentsUS6277987B1Aug 21, 2001
Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives
NOVARTIS AG49 citations89
US7138432B1Nov 21, 2006
Arylsulfonamido-substituted hydroxamic acid derivatives
NOVARTIS AG3 citations60
US6410580B1Jun 25, 2002
Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
NOVARTIS AG3 citations60
US8034810B2Oct 11, 2011
Arylsulfonamido-substituted hydroxamic acid derivatives
NOVARTIS AG0 citations50
US6461848B1Oct 8, 2002
Human heparanase polypeptide and cDNA
NOVARTIS AG1 citations42
UNIV TEXAS
3 patentsUS5332812AJul 26, 1994
Solid-phase substrate containing modified heparin
UNIV TEXAS50 citations94
US5262403ANov 16, 1993
Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
UNIV TEXAS51 citations94
US4859581AAug 22, 1989
Endoglycosidase assay
UNIV TEXAS57 citations94